인쇄하기
취소

Kyowa Hakko Kirin’s Neulasta meeting better health insurance benefits

Published: 2018-04-03 16:22:48
Updated: 2018-04-03 16:22:48

The health insurance standards of Kyowa Hakko Kirin Korea’s Neulasta Prefilled Syringe(generic name: pegfilgrastim) has been partially extensively applied since 1 April.

Neulasta is a daily long-acting drug out of granulocyte colony-stimulating factor(G-CSF) drugs prescribed to decrease incidence of febrile neutropenia and period of febrile neutropenia for cancer patients who received cytotoxi...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.